Charles Stellar was appointed president and CEO of WEDI, which gives counsel to HHS on health IT and health information exchange. Stellar, who has served as WEDI's interim CEO since Devin Jopp's resignation in January, was chosen for his 35 years of experience in association management and health care.
A collaboration has brought together Direct Urgent Care, Eko Devices and drchrono to provide clinicians with a three-step process allowing for heart and lung sounds to be integrated into EHRs for clinical documentation. The process calls for the use of the Eko Core Digital Stethoscope in capturing sounds, which are then transmitted to a HIPAA-compliant mobile app and uploaded to the drchrono EHR platform for integration.
The Population Health Risk Assessment Support Engine, a tool developed by doctors from the Children's Hospital of Philadelphia, has won the top prize of $30,000 in the Closing the Data Divide competition for health information exchange technologies. The system provides hospitals with clinical decision support and helps them determine at-risk patients, while also facilitating data exchange between providers and public health agencies.
A $7 million grant was given to the State University of New York by the Patient-Centered Outcomes Research Institute for SUNY's five-year project that will determine if the recovery rate for drug users diagnosed with hepatitis C infections will improve with the use of telehealth services. The project will involve 12 methadone clinics in the state and will compare virus eradication rates, treatment adherence and completion, and patient satisfaction to results from patients given in-person visits with physicians.
Congress should urge HHS to create a coordinated strategy against cyberattacks instead of focusing on organizational reporting structures, said Intermountain Chief Information Officer and CHIME Board Chair Marc Probst. "What's central to this conversation is meaningful coordination, avoiding any unintended consequences of complex reporting that instead may impede the coordination and flow of information necessary to thwart cyberthreats," Probst said.
A CDC survey revealed that 33% of adults ages 65 and older use health IT, compared with 54.8% of those ages 18 to 64. The survey also found a higher percentage of adults 18 to 64 participated in online chat groups to get health information, filled a prescription or made an appointment online, and sent emails to their providers than those 65 and older.
Most antibiotics kill beneficial bacteria along with harmful pathogens, and a mouse study found that broad-spectrum treatments significantly changed gut microbiomes, thinned the colon mucosa and reduced immune cell counts. A second study showed that mice treated with broad-spectrum antibiotics had fewer Ly6Chi monocytes in their bone marrow, blood and brains, and they did not perform well on memory tests. Meanwhile, St. Jude Children's Research Hospital is testing a drug that targets only staphylococcus. The microbiomes of mice treated with the experimental agent were more stable and rebounded more rapidly than the microbiomes of mice treated with standard antibiotics.
A list of health IT products and developers, including EHR systems, that no longer conform with the requirements of the Health IT Certification Program, such as health information exchange capabilities, patient privacy measures and quality care assurance, has been published by the ONC. The surveillance results, which can be viewed on the agency's website, were released to increase transparency in the health care sector and give stakeholders more information when they purchase HIT products.
Ann Arbor, Mich.-based Complete Chiropractic & Bodywork Therapies notified 4,082 patients about a potential data breach after it learned on March 19 that its server was infected with malware. The server contained patient names, birth dates, addresses, diagnoses and Social Security numbers, although the data were encrypted.
C57Bl/6 knockout mice have a mutation that disrupts Dock2 gene function, and studies using that mouse strain should be scrutinized, researchers at Ragon Institute reported in Cell Reports. "In light of these findings, published studies involving immune or hematopoietic phenotypes in which these C57BL/6 mice have been used as controls, as experimental animals, or for backcrossing will need to be reinterpreted," the researchers wrote. Whole-genome sequencing showed a duplication of the Dock2 gene on chromosome 11, which alters immune function in the mice.
- Page 1